86C.F BIOTALYS NV

Basic Materials Chemicals Frankfurt Exchange
1.92 EUR
Close of Nov 11, 2026
1.55 4.77
Market cap
EUR 87.4M
P/E
-
P/B
6.07x
ROE
-130.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 86C.F undervalued?

Graham number

The Graham number of BIOTALYS NV cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIOTALYS NV fundamental analysis

No fundamental analysis for BIOTALYS NV yet.

BIOTALYS NV stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIOTALYS NV

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and other fungi in fruits and vegetables; B…

Full company profile